IFNG and breast carcinoma: Breast cancer patients with increased signaling responsiveness to immunosuppressive cytokines (IL-10 and TGF-β) in Treg II cells had worse RFS, whereas patients with increased signaling responsiveness to immunostimulatory cytokines (IL-4 and IFN-γ) in Treg II cells had better RFS.